|
|
|
|
|
|
|
|
|
|
Previous: NUTRACEUTIX INC, 10QSB, EX-10.1, 2000-11-14 |
Next: NUTRACEUTIX INC, 10QSB, EX-27, 2000-11-14 |
<PAGE> 1
EXHIBIT 11.1
NUTRACEUTIX, INC.
COMPUTATION OF EARNINGS (LOSS) PER SHARE
<TABLE>
<CAPTION>
Three months ended Nine months ended
September 30, September 30,
----------------------------------- -----------------------------------
2000 1999 2000 1999
------------ ------------ ------------ ------------
<S> <C> <C> <C> <C>
PRIMARY AND FULLY DILUTED:
Weighted average shares 17,698,588 17,489,812 17,563,589 17,299,794
outstanding
Effect of dilutive stock 1,728,479 2,105,832 1,728,479 --
equivalents
Effect of shares over market (1,141,800) (1,262,066) (1,141,800) --
------------ ------------ ------------ ------------
Total 18,285,267 18,333,578 18,150,268 17,299,794
Net earnings (loss) $ 442,035 $ 244,900 $ 98,894 $ (33,591)
============ ============ ============ ============
Primary net earnings (loss) per $ 0.025 $ 0.014 $ 0.006 $ (0.002)
share
============ ============ ============ ============
Fully diluted net earnings
(loss) per share $ 0.024 $ 0.013 $ 0.005 $ (0.002)
============ ============ ============ ============
</TABLE>
22
|
|